Table.

Participant characteristics and vaccine information

		Patients
Mean age, years (SD)		49·31 (21·19)
Sex
	Female	676/1151 (58·7%)
	Male	475/1151 (41·3%)
Diagnosis
	Cognitive disorder	113/1151 (9·8%)
	Psychotic disorder	243/1151 (21·1%)
	Bipolar disorder	77/1151 (6·7%)
	Depressive disorder	159/1151 (13·8%)
	Developmental disorder	17/1151 (1·5%)
	Anxiety disorder	94/1151 (8·2%)
	Personality disorder	134/1151 (11·6%)
	Substance use disorder	62/1151 (5·4%)
	Eating disorder	45/1151 (3·9%)
	Adjustment disorder	142/1151 (12·3%)
	Other	65/1151 (5·6%)
Vaccine status
	Fully	936/1151 (81·3%)
	Partly	134/1151 (11·6%)
	Refused	81/1151 (7·0%)
Vaccine type
	mRNA-1273 (Moderna)	590/1070 (55·1%)
	BNT162b2 (Pfizer–BioNTech)	371/1070 (34·7%)
	ChAdOx1 (Oxford–AstraZeneca)	94/1070 (8·8%)
	Ad26.COV2.S (Johnson & Johnson)	14/1070 (1·3%)

Data are n/N (%), unless otherwise stated.